Trademark: 87696005
Word
HYLEUKIN
Status
Dead
Status Code
606
Status Date
Monday, July 13, 2020
Serial Number
87696005
Mark Type
4000
Filing Date
Thursday, November 23, 2017
Published for Opposition
Tuesday, April 17, 2018
Abandoned Date
Monday, July 13, 2020

Trademark Owner History
Genexine, Inc. - Owner At Publication

Classifications
5 Antibiotics; Anti-cancer preparations; Anti-inflammatory preparations, namely, anti-inflammatory gels, ointments, salves, sprays, creams, pills, powders, granules, tablets, capsules, depots, suppository, syrup, tinctures and emulsion; Antiviral agent against human papilloma virus; Blood solvent, namely, blood plasma, albumin, globulin, fibrinogen, thrombocyte and platelets; Cardiovascular pharmaceutical preparations for the treatment and prevention of heart and vascular diseases; Dermatological pharmaceutical products; DNA vaccines; Drugs for medical purposes, namely, pharmaceutical drug preparations for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; Injectable pharmaceuticals for medical purposes, namely, for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; Medicines for sensory organs, namely, pharmaceutical preparations for the prevention, treatment, and cure of diseases and conditions impacting the eyes, ears, nose, mouth and nervous system; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical preparations and compositions for the treatment and prevention of cancer; Pharmaceutical preparations for activating cellular function; Pharmaceutical preparations for anticancer immunotherapy; Pharmaceutical preparations for digestive organs, namely, for the prevention, treatment, and cure of diseases and conditions impacting digestive organs; Pharmaceutical preparations for gene therapy; Pharmaceutical preparations for immunomodulatory purposes, namely, for the regulation of immune functions; Pharmaceutical preparations for immunotherapy; Pharmaceutical preparations for preventing and treating obese; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of cardiovascular disease; Pharmaceutical preparations for the treatment of cervical cancer; Pharmaceutical preparations for the treatment of cervical intraepithelial neoplasia; Pharmaceutical preparations for the treatment of cervical pre-cancer; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of head and neck cancer; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for the treatment of multiple sclerosis; Pharmaceutical preparations for the treatment of osteoporosis; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating malignant tumours; Pharmaceutical preparations for urogenital organs; Pharmaceutical preparations for wounds; Pharmaceutical products and preparations, namely, for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical products for the treatment of viral and infectious diseases; Pharmaceutical products for the treatment of viral diseases; Preventive vaccines; Preventive vaccines against human papilloma virus infections; Therapeutic vaccines; and Vaccines

Trademark Events
Jul 13, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 13, 2020
Abandonment - No Use Statement Filed
Dec 4, 2019
Notice Of Approval Of Extension Request E-Mailed
Dec 2, 2019
Extension 3 Granted
Dec 2, 2019
Extension 3 Filed
Dec 2, 2019
Teas Extension Received
Jun 8, 2019
Notice Of Approval Of Extension Request E-Mailed
Jun 6, 2019
Extension 2 Granted
Jun 6, 2019
Extension 2 Filed
Jun 6, 2019
Teas Extension Received
Dec 13, 2018
Notice Of Approval Of Extension Request E-Mailed
Dec 11, 2018
Extension 1 Granted
Dec 11, 2018
Extension 1 Filed
Dec 11, 2018
Teas Extension Received
Jun 12, 2018
Noa E-Mailed - Sou Required From Applicant
Apr 17, 2018
Official Gazette Publication Confirmation E-Mailed
Apr 17, 2018
Published For Opposition
Mar 28, 2018
Notification Of Notice Of Publication E-Mailed
Mar 9, 2018
Approved For Pub - Principal Register
Mar 8, 2018
Assigned To Examiner
Dec 5, 2017
New Application Office Supplied Data Entered In Tram
Nov 27, 2017
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24